Bombay:
Actor Rhea Chakraborty and his brother Showik told the Bombay High Court that the Narcotics Control Bureau (NCB), which is investigating a drug case linked to the death of actor Sushant Singh Rajput, n has no jurisdiction to initiate the investigation, their lawyer Satish Maneshinde told me.
Mr Maneshinde told the court that the drug case handled by the BCN should have been transferred to the CBI, which is investigating Mr Rajput’s death.
The court made no order on the Chakrabortys’ bail requests and suggested that the BCN file a response by Monday.
The siblings were indicted by the PNE under various sections of the Narcotics and Psychotropic Substances Act (NDPS). Currently in judicial custody, the two had contacted the High Court earlier this week to challenge the orders of a special NDPS court in the city that had dismissed their bail requests.
Mr Maneshinde told a single bench chaired by Judge Sarang Kotwal that the Supreme Court, while hearing pleadings calling for a CBI investigation into Mr Rajput’s alleged suicide, ruled that all cases related to the death would be the subject of a CBI investigation.
“The CBI, which is already investigating the death case, is also empowered to investigate the cases under the NDPS Act,” Maneshinde said. “Therefore, the NCB should have transferred the investigation to the CBI after the registration of the offenses under the NDPS law”, he said.
Lawyer said Rhea Chakraborty and Showik should not have been listed under strict section 27A of the NDPS Act, which concerns drug funding and provides for a jail term of up to 10 years on conviction.
However, the siblings and others arrested in the case argued in their bail requests that the NCB had only seized 59 grams of the drug, which cannot be characterized as a commercial quantity. and therefore, they should not have been listed under 27A.